Alexandria Hammond
Stock Analyst at B of A Securities
(0.96)
# 2176
Out of 5,372 analysts
16
Total ratings
70.00%
Success rate
0.09%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
AKRO Akero Therapeutics | Maintains: Strong Buy | 63 64 | 55.42 | 15.48% | 4 | May 27, 2025 | |
REGN Regeneron Pharmaceut... | Initiates Coverage On: Outperform | 1150 | 508.9 | 125.98% | 1 | Nov 15, 2024 | |
PFE Pfizer | Initiates Coverage On: Underperform | 25 | 24 | 4.17% | 1 | Nov 15, 2024 | |
MRNA Moderna | Initiates Coverage On: Underperform | 40 | 25.57 | 56.43% | 1 | Nov 15, 2024 | |
MRK Merck & Co | Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 1000 | 791.46 | 26.35% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 190 | 152.38 | 24.69% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 110 | 108.12 | 1.74% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 205 | 185.53 | 10.49% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Underperform | 150 | 279.69 | -46.37% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 30 | 9.94 | 201.81% | 1 | Apr 22, 2024 |